Key result
Double deletion of AT2 and Mas receptors in male mice significantly accelerated aging-associated muscle weakness compared to wild-type mice from 18 months of age.
Why the study?
It was unclear whether AT2 and Mas receptors contribute to the aging process complementarily, particularly regarding aging-related muscle weakness, given that deletion of Mas alone did not affect aging.
AT2 and Mas receptors complement each other in preventing local activation of the renin-angiotensin system and protecting against aging-associated muscle weakness in mice.
Background The activation of AT2 (angiotensin II type 2 receptor ) and Mas receptor by angiotensin II and angiotensin-(1-7), respectively, is the primary process that counteracts activation of the canonical renin-angiotensin system (RAS). Although inhibition of canonical RAS could delay the progression of physiological aging, we recently reported that deletion of Mas had no impact on the aging process in mice. Here, we used male mice with a deletion of only AT2 or a double deletion of AT2 and Mas to clarify whether these receptors contribute to the aging process in a complementary manner, primarily by focusing on aging-related muscle weakness. Methods and Results Serial changes in grip strength of these mice up to 24 months of age showed that AT2/Mas knockout mice, but not AT2 knockout mice, had significantly weaker grip strength than wild-type mice from the age of 18 months. AT2/Mas knockout mice exhibited larger sizes, but smaller numbers and increased frequency of central nucleation (a marker of aged muscle) of single skeletal muscle fibers than AT2 knockout mice. Canonical RAS-associated genes, inflammation-associated genes, and senescence-associated genes were highly expressed in skeletal muscles of AT2/Mas knockout mice. Muscle angiotensin II content increased in AT2/Mas knockout mice. Conclusions Double deletion of AT2 and Mas in mice exaggerated aging-associated muscle weakness, accompanied by signatures of activated RAS, inflammation, and aging in skeletal muscles. Because aging-associated phenotypes were absent in single deletions of the receptors, AT2 and Mas could complement each other in preventing local activation of RAS during aging.
No takes yet. Share an insight, caveat, or question.
Takeshita et al. (2021) studied Aging-related muscle weakness. Double deletion of AT2 and Mas receptors vs. Wild-type mice and AT2 knockout mice was evaluated on Grip strength. Double deletion of AT2 and Mas receptors in male mice significantly accelerated aging-associated muscle weakness compared to wild-type mice from 18 months of age.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: